Herbst Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $392K | Sell |
4,725
-5
| -0.1% | -$415 | 0.23% | 46 |
|
|
2025
Q1 | $384K | Sell |
4,730
-100
| -2% | -$8.11K | 0.27% | 46 |
|
|
2024
Q4 | $435K | Buy |
4,830
+800
| +20% | +$72K | 0.27% | 54 |
|
|
2024
Q3 | $398K | Hold |
4,030
| – | – | 0.25% | 53 |
|
|
2024
Q2 | $374K | Hold |
4,030
| – | – | 0.23% | 59 |
|
|
2024
Q1 | $382K | Buy |
4,030
+100
| +3% | +$9.49K | 0.24% | 57 |
|
|
2023
Q4 | $351K | Hold |
3,930
| – | – | 0.23% | 58 |
|
|
2023
Q3 | $287K | Sell |
3,930
-331
| -8% | -$24.2K | 0.2% | 63 |
|
|
2023
Q2 | $355K | Buy |
4,261
+11
| +0.3% | +$915 | 0.25% | 62 |
|
|
2023
Q1 | $324K | Buy |
4,250
+20
| +0.5% | +$1.52K | 0.23% | 65 |
|
|
2022
Q4 | $351K | Hold |
4,230
| – | – | 0.28% | 62 |
|
|
2022
Q3 | $336K | Hold |
4,230
| – | – | 0.28% | 65 |
|
|
2022
Q2 | $324K | Buy |
+4,230
| New | +$324K | 0.26% | 67 |
|